Distribution of rRNA genes in breeds of domestic pig studied by non-radioactive in situ hybridization and selective silver-staining

Autor: de Haan NA, Bosma AA, Mellink CHM, Wiegant J

Publikováno v: Genetics Selection Evolution, Vol 23, Iss Suppl 1, Pp S168-S172 (1991)

Externí odkaz: https://doaj.org/article/6d762c2e18f94266b0539dd0317294b5

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.

Autor: Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Arslan Ö; Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkan F; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey., Herishanu Y; Department of Hematology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Ferhanoglu B; Department of Hematology, Koç University Medical Faculty, Istanbul, Turkey., Diaz MG; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Leber B; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada., Montillo M; Department of Haematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Panayiotidis P; First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Rossi D; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Skarbnik A; Lymphoproliferative Disorders Program, Novant Health Cancer Institute, Charlotte, NC, USA; John Theurer Cancer Center, Hackensack, NJ, USA., Tempescul A; Department of Clinical Hematology, University Teaching Hospital Brest, Brest, France., Turgut M; Department of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey., Mellink CH; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Kevie-Kersemaekers AF; Department of Genetics, UMC Utrecht, Utrecht, The Netherlands., Lanham S; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Sale B; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Del Rio L; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Popovic R; AbbVie, North Chicago, IL, USA., Chyla BJ; AbbVie, North Chicago, IL, USA., Busman T; AbbVie, North Chicago, IL, USA., Komlosi V; AbbVie, North Chicago, IL, USA., Wang X; AbbVie, North Chicago, IL, USA., Sail K; AbbVie, North Chicago, IL, USA., Pena GE; AbbVie, North Chicago, IL, USA., Vizkelety T; AbbVie, North Chicago, IL, USA., Forconi F; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, UK. Electronic address: f.forconi@soton.ac.uk.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Apr; Vol. 25 (4), pp. 463-473. Date of Electronic Publication: 2024 Mar 08.

Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease.

Autor: van Andel H; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kocemba KA; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Biochemistry, Jagiellonian University Medical College, Krakow, Poland., de Haan-Kramer A; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Mellink CH; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Piwowar M; Department of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Krakow, Poland., Broijl A; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands., van Duin M; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands., Sonneveld P; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands., Maurice MM; Department of Cell Biology, University MC Utrecht, Utrecht, The Netherlands., Kersten MJ; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Spaargaren M; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Pals ST; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Oncogene [Oncogene] 2017 Apr; Vol. 36 (15), pp. 2105-2115. Date of Electronic Publication: 2016 Oct 24.

Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.

Autor: Santos J; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal., Cerveira N, Bizarro S, Ribeiro FR, Correia C, Torres L, Lisboa S, Vieira J, Mariz JM, Norton L, Snijder S, Mellink CH, Buijs A, Shih LY, Strehl S, Micci F, Heim S, Teixeira MR

Publikováno v: Leukemia research [Leuk Res] 2010 May; Vol. 34 (5), pp. 615-21. Date of Electronic Publication: 2009 Sep 12.

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.

Autor: Mous R, Jaspers A, Luijks DM, Mellink CH, van Oers MH, Kater AP, Eldering E

Publikováno v: Leukemia [Leukemia] 2009 Jul; Vol. 23 (7), pp. 1352-5. Date of Electronic Publication: 2009 Apr 02.